CUREVAC NV (5CV.DE) Forecast, Price Target & Analyst Ratings

FRA:5CV • NL0015436031

Current stock price

3.892 EUR
+0.01 (+0.36%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CUREVAC NV (5CV.DE).

Forecast Snapshot

Consensus Price Target

Price Target
€4.02
+ 3.22% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 8, 2026
Period
Q4 / 2025
EPS Estimate
€0.05
Revenue Estimate
44.778M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
74.55%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€4.02
Upside
+ 3.22%
From current price of €3.89 to mean target of €4.02, Based on 11 analyst forecasts
Low
€1.70
Median
€4.68
High
€4.86

Price Target Revisions

1 Month
-2.38%
3 Months
-4.19%

Price Target Summary

11 Wall Street analysts provided a forecast for the next 12 months for 5CV.DE. The average price target is 4.02 EUR. This implies a price increase of 3.22% is expected in the next year compared to the current price of 3.892.
The average price target has been revised downward by 4.19% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

5CV Current Analyst Rating5CV Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

5CV Historical Analyst Ratings5CV Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10

Analyst Ratings Consensus

ChartMill Buy Consensus
74.55%
5CV.DE was analyzed by 11 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about 5CV.DE.
In the previous month the buy percentage consensus was at a similar level.
5CV.DE was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2021-06-17B of A SecuritiesDowngrade Buy -> Neutral
2021-04-26GuggenheimInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 8, 2026
Period
Q4 / 2025
EPS Estimate
€0.05
Revenue Estimate
44.778M
Revenue Q2Q
209.48%
EPS Q2Q
138.85%
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
33.33%
EPS (1 Month)
0.00%
EPS (3 Months)
966.60%

Next Earnings Summary

5CV.DE is expected to report earnings on 4/8/2026. The consensus EPS estimate for the next earnings is 0.05 EUR and the consensus revenue estimate is 44.78M EUR.
The next earnings revenue estimate has been revised upward by 33.33% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
5CV.DE revenue by date.5CV.DE revenue by date.
67.4M
-34.56%		53.758M
-20.24%		535.18M
895.54%		72.687M
-86.42%		89.921M
23.71%		151.53M
68.51%		201.05M
32.68%		253.93M
26.30%		293.89M
15.74%		306.03M
4.13%		197.66M
-35.41%
EBITDA
YoY % growth
5CV.DE ebitda by date.5CV.DE ebitda by date.
-201.3M
56.52%		-247.497M
-22.95%		196.491M
179.39%		-113.447M
-157.74%		-113.488M
-0.04%		-32.747M
71.14%		223.37M
782.11%		324.72M
45.37%		422.96M
30.25%		N/AN/A
EBIT
YoY % growth
5CV.DE ebit by date.5CV.DE ebit by date.
-225M
53.00%		-270.883M
-20.39%		177.682M
165.59%		-137.999M
-177.67%		-97.158M
29.59%		-58.146M
40.15%		49.397M
184.95%		99.982M
102.41%		135.32M
35.34%		144.48M
6.77%		31.104M
-78.47%
Operating Margin
5CV.DE operating margin by date.5CV.DE operating margin by date.
-333.83%-503.89%33.20%-189.85%-108.05%-38.37%24.57%39.37%46.04%47.21%15.74%
EPS
YoY % growth
5CV.DE eps by date.5CV.DE eps by date.
-1.24
61.67%		-1.18
4.84%		0.73
161.86%		-0.47
-163.99%		-0.44
6.55%		-0.10
77.80%		-0.54
-460.42%		-0.55
-1.90%		-0.56
-1.84%		N/AN/A

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25
EPS
Q2Q % growth		0.05
138.85%
Revenue
Q2Q % growth		44.778M
209.48%
EBITDA
Q2Q % growth		-25.422M
-1.89%
EBIT
Q2Q % growth		7.639M
117.46%

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

5CV.DE Yearly Revenue VS Estimates5CV.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
5CV.DE Yearly EPS VS Estimates5CV.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -1 -2 -3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-28.72%
EPS Next 5 Year
-22.50%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-30.85%
Revenue Next 5 Year
-11.14%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-29.43%
EBIT Next 5 Year
10.78%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CUREVAC NV / 5CV.DE Forecast FAQ

What do analysts expect the price target to be for CUREVAC NV (5CV.DE)?

11 analysts have analysed 5CV.DE and the average price target is 4.02 EUR. This implies a price increase of 3.22% is expected in the next year compared to the current price of 3.892.

What is the next earnings date for 5CV stock?

CUREVAC NV (5CV.DE) will report earnings on 2026-04-08, after the market close.

What are the consensus estimates for CUREVAC NV (5CV.DE) next earnings?

The consensus EPS estimate for the next earnings of CUREVAC NV (5CV.DE) is 0.05 EUR and the consensus revenue estimate is 44.78M EUR.

What is the consensus rating for 5CV stock?

The consensus rating for CUREVAC NV (5CV.DE) is 74.5455 / 100 . This indicates that analysts generally have a positive outlook on the stock.